1. Krachmer JH, Mannis MJ, Holland EJ. Cornea: fundamentals, diagnosis and management, vol. 1. Philadelphia, PA: Elsevier/Mosby; 2011.
2. Jimenez J, Sakthivel M, Nischal KK, Fedorchak MV. Drug delivery systems and novel formulations to improve treatment of rare corneal disease. Drug Discovery Today. 2019;24:1564–74. https://doi.org/10.1016/j.drudis.2019.03.005.
3. Gahl WA, Thoene JG, Schneider JA. Cystinosis. The New England Journal of Medicine. 2002;347(2):111–21. https://doi.org/10.1056/NEJMra020552.
4. Nesterov G, Gahl WA. “Cystinosis.” In GeneReviews®, edited by Margaret P. Adam, Holly H. Ardinger, Roberta A. Pagon, Stephanie E. Wallace, Lora JH Bean, Karen Stephens, and Anne Amemiya. Seattle (WA): University of Washington, Seattle, 1993. http://www.ncbi.nlm.nih.gov/books/NBK1400/.
5. Kaiser-Kupfer MI, Caruso RC, Minkler DS, Gahl WA. Long-term ocular manifestations in nephropathic cystinosis. Archives of Ophthalmology (Chicago, Ill: 1960). 1986;104(5):706–11.